Drug Trial Radar · NCT02013115
Curosurf/Budesonide for Infants With Respiratory Distress Syndrome
Last checked: Nov 20, 2026Latest source record: Dec 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jan 1, 2015
Primary completion
Oct 30, 2017
Study completion Oct 30, 2017
Sponsor
- Lead sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 17, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 12 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Infants showing high local pulmonary inflammation diagnosted by respiratory distress syndrome usually need the second or more pulmonary surfactant and is easier to developing to Brochopulmonary. Cursurf is used worldwide in infants with respiratory distress syndrome, Budesonide is a glucocorticoid with a high local anti-inflammatory effect.Our hypothesis is Cursurf combined with Budesonide could reduced the need of Cursurf and incidence of Brochopulmonary dysplasia.
Conditions
- Respiratory Distress Syndrome
Interventions
BudesonideDrug
Experimental: Cursurf and Budesonide The baby with respiratory distress syndrome was given Cursurf and Budesonide through intubation
Primary outcomes
What the sponsor says the trial is designed to measure.
- need of pulmonary surfactantTime frame: one month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University
Chongqing, Chongqing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.